Recent studies highlight the significance of PAPP-A in cardiovascular diseases (CVDs), particularly coronary artery disease (CAD), due to its role in promoting atherosclerosis and serving as a biomarker for diagnosis and prognosis. This evidence concerns the gene PAPPA and coronary artery disorder.